Copyright
©The Author(s) 2018.
World J Gastrointest Oncol. Nov 15, 2018; 10(11): 410-420
Published online Nov 15, 2018. doi: 10.4251/wjgo.v10.i11.410
Published online Nov 15, 2018. doi: 10.4251/wjgo.v10.i11.410
All patients (%) | RCC (%) | LCC (%) | |||
DFS (mo) | Stage II | Stage III | Stage II | Stage III | |
12 | 97.9 | 98.9 | 96.2 | 98.0 | 96.8 |
36 | 89.8 | 93.9 | 83.6 | 94.5 | 81.9 |
60 | 87.0 | 93.1 | 79.4 | 91.8 | 78.2 |
90 | 84.9 | 92.6 | 75.9 | 91.3 | 76.7 |
120 | 84.4 | 92.0 | 75.0 | 90.5 | 74.4 |
180 | 82.7 | 90.3 | 73.2 | 90.5 | 72.2 |
OS (mo) | |||||
12 | 99.8 | 99.3 | 100.0 | 99.7 | 100.0 |
36 | 96.7 | 96.2 | 95.5 | 99.3 | 94.4 |
60 | 92.4 | 94.5 | 86.2 | 97.0 | 87.9 |
90 | 89.5 | 94.0 | 82.5 | 94.4 | 86.4 |
120 | 87.6 | 92.7 | 78.9 | 93.8 | 82.9 |
180 | 86.6 | 92.7 | 78.9 | 92.1 | 82.9 |
- Citation: Sakin A, Arici S, Secmeler S, Can O, Geredeli C, Yasar N, Demir C, Demir OG, Cihan S. Prognostic significance of primary tumor localization in stage II and III colon cancer. World J Gastrointest Oncol 2018; 10(11): 410-420
- URL: https://www.wjgnet.com/1948-5204/full/v10/i11/410.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v10.i11.410